Role of Fibroblasts in the Subtype Specific Therapeutic Effects of Nintedanib in Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Gabasa, Marta [1 ]
Ikemori, Rafael [1 ]
Solca, Flavio [2 ]
Hilberg, Frank [2 ]
Reguart, Noemi [3 ]
Alcaraz, Jordi [1 ]
机构：
[1] Univ Barcelona, Dept Biomed, Fac Med, Barcelona, Spain
[2] Boehringer Ingelheim Rcv GmbH & Co Kg, Vienna, Austria
[3] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
nintedanib; TGF-beta; tumor microenvironment; cancer associated fibroblasts;
D O I：
10.1016/j.jtho.2016.11.292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA11.06
引用
收藏
页码：S287 / S288
页数：2
相关论文
共 50 条
  • [41] Role of gefitinib (G) in heavily pretreated non-small cell lung cancer (NSCLC)
    Tamburini, E.
    Tassinari, D.
    Pasquini, E.
    Papi, M.
    Possenti, C.
    Drudi, F.
    Castellani, C.
    Santelmo, C.
    Carloni, F.
    Ravaioli, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Prognostic role of nitrotyrosines in surgically resected non-small cell lung cancer (NSCLC)
    Toschi, L.
    Colombo, P.
    Soldani, C.
    Giordano, L.
    Finocchiaro, G.
    Siracusano, L.
    Gianoncelli, L.
    Incarbone, M.
    Destro, A.
    Alloisio, M.
    Terracciano, L.
    Varella-Garcia, M.
    Cappuzzo, F.
    Roncalli, M.
    Viola, A.
    Santoro, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] The role of imaging in screening, diagnosis and staging of non-small cell lung cancer (NSCLC)
    Rankin, SC
    EJC SUPPLEMENTS, 2004, 2 (04): : 7 - 14
  • [44] Assessment of the role of factor I in non-small cell lung cancer (NSCLC) progression
    Felberg-Mietka, Anna
    Urban, Aleksandra
    Kuzniewska, Alicja
    Stasilojc, Grzegorz
    Bienkowski, Michal
    Pio, Ruben
    Montuenga, Luis
    Spaapen, Robbert
    Blom, Anna
    Okroj, Marcin
    MOLECULAR IMMUNOLOGY, 2022, 141 : 129 - 129
  • [45] The Impact Of Renal Function On Therapeutic Options For Advanced Non-small Cell Lung Cancer (NSCLC)
    Cenik, B. K.
    Sun, H.
    Rasco, D. W.
    Gerber, D. E.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S244 - S244
  • [46] Evaluating CD38 as a therapeutic target in non-small cell lung cancer (NSCLC)
    Kinder, Michelle
    Mendonca, Mark
    Syed, Khaja
    Parker, Melissa
    Wilkinson, Patrick
    Thompson, Edward
    Chu, Gerald
    Chiu, Christopher
    Hutnick, Natalie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [47] The impact of renal function on therapeutic options for advanced non-small cell lung cancer (NSCLC)
    Cenik, Bercin Kutluk
    Rasco, Drew Warren
    Sun, Han
    Gerber, David E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Therapeutic vaccines in non-small cell lung cancer
    Socola, Francisco
    Scherfenberg, Naomi
    Raez, Luis E.
    IMMUNOTARGETS AND THERAPY, 2013, 2 : 115 - 124
  • [49] The use of second line docetaxel and nintedanib for non-small cell lung cancer
    Wasim, Z.
    Chowdhury, S.
    LUNG CANCER, 2018, 115 : S31 - S31
  • [50] Therapeutic advances in non-small cell lung cancer
    Vallieres, Eric
    Peters, Solange
    Van Houtte, Paul
    Dalal, Paras
    Lim, Eric
    THORAX, 2012, 67 (12) : 1097 - 1101
12345